Chris Davis Viatris Inc Transaction History
Davis Selected Advisers
- $16.8 Billion
- Q4 2024
A detailed history of Chris Davis (Davis Selected Advisers) transactions in Viatris Inc stock. As of the latest transaction made, Davis Selected Advisers holds 62,573,562 shares of VTRS stock, worth $569 Million. This represents 4.62% of its overall portfolio holdings.
Number of Shares
62,573,562
Previous 62,647,266
0.12%
Holding current value
$569 Million
Previous $727 Million
7.11%
% of portfolio
4.62%
Previous 4.18%
Shares
17 transactions
Others Institutions Holding VTRS
# of Institutions
1,142Shares Held
988MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.29 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$843 Million0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$580 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$534 Million0.08% of portfolio
-
Pacer Advisors, Inc. Malvern, PA35.2MShares$320 Million1.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...